New Trends in Cutaneous Melanoma Surgery

Jacopo Scala1, Aleksandra Vojvodic2, Petar Vojvodic3

  • 1University G. Marconi, Rome, Italy.

Insights

Melanoma management is evolving beyond surgery with new therapies like BRAF inhibitors, MEK inhibitors, and anti-PD-1 antibodies. This review discusses optimal surgical strategies alongside these advancements for advanced melanoma.

Area of Science:

  • Oncology
  • Dermatology
  • Surgical Oncology

Background:

  • Wide surgical excision and sentinel node biopsy are traditional melanoma treatments.
  • Emerging systemic therapies are transforming melanoma management, including advanced stages.

Purpose of the Study:

  • To review current data on optimal surgical management for malignant melanoma patients.
  • To integrate surgical strategies with new systemic therapies for melanoma.

Main Methods:

  • Literature review of recent advancements in melanoma treatment.
  • Analysis of data on surgical excision and systemic therapies (BRAF/MEK inhibitors, anti-PD-1 antibodies).

Main Results:

  • Systemic therapies show significant efficacy in controlling advanced melanoma.
  • Optimal surgical management needs to be considered alongside new systemic treatments.

Conclusions:

  • The evolving landscape of melanoma treatment requires a combined approach of surgery and novel systemic therapies.
  • This review provides insights into optimizing surgical care for melanoma patients in the era of targeted and immune therapies.